SOLID MALIGNANCIES
Clinical trials for SOLID MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new SOLID MALIGNANCIES trials appear
Sign up with your email to follow new studies for SOLID MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control OngoingThis study tests two immunotherapy drugs, durvalumab and tremelimumab, alone or together with standard chemotherapy, in people with advanced solid cancers that cannot be cured. The main goal is to find the safest dose that does not cause severe side effects. About 153 participant…
Matched conditions: SOLID MALIGNANCIES
Phase: PHASE1 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated May 26, 2026 08:14 UTC
-
New cancer drug candidate GS-9716 enters first human tests
Disease control OngoingThis early-phase study tests a new drug called GS-9716 (zamzetoclax) in about 145 people with advanced solid tumors that have not responded to other treatments. The drug is given alone or with other cancer therapies to find the safest dose and check for side effects. The goal is …
Matched conditions: SOLID MALIGNANCIES
Phase: PHASE1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 26, 2026 08:12 UTC